ITMN Stock News 35.44 05/13/2014 16:15:02 Intermune Inc (ITM

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Intermune Inc (ITMN) 35.44 $ITMN

Insider Trading Alert - IPXL, ITMN And GMCR Traded By Insiders
at The Street - Tue May 13, 11:30AM CDT
Stocks with insider trader activity include IPXL, ITMN and GMCR

Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago InterMune Is Up 12.2% (ITMN)
Comtex SmarTrend(R) - Mon May 12, 11:34AM CDT
11 days ago, on May 1st, 2014, InterMune (NASDAQ:ITMN) reported its earnings. Analysts, on average, expected a loss of $0.62 per share on sales of $28.4 million. InterMune actually reported a loss of $0.59 per share on sales of $30.3 million, beating EPS estimates by $0.03 and beating revenue estimates by $1.9 million. Shares of InterMune have climbed from $32.16 to $36.07, representing a gain of 12.2% since the company reported earnings 11 days ago.

InterMune Announces Upcoming Data Presentations at 2014 American Thoracic Society Meeting
PR Newswire - Mon May 12, 7:00AM CDT
InterMune, Inc. (NASDAQ: ITMN) today announced that several investigational molecules and data from studies of pirfenidone will be presented at the 2014 International Conference of the American Thoracic Society (ATS), May 16 - 21, in San Diego, Calif. in a total of 18 abstracts. Updates on InterMune's small molecule fibrosis research programs, including pirfenidone analogs and inhibitors of LPA1 and LOXL2, will be presented at the meeting. Additionally, data will be presented from studies of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF), including the primary efficacy and safety analyses of the Phase 3 ASCEND trial, as well as other data that further characterize the safety profile of pirfenidone.

5 of Last Week's Biggest Winners
Rick Munarriz, The Motley Fool - Motley Fool - Sun May 11, 11:00AM CDT
It was a rocky week on Wall Street, with Nasdaq stocks inching lower and the Dow inching higher, but there were plenty of stocks really making some serious moves. Let's take a closer look at five of this past week's biggest scorchers. ...

This Relative Strength Play Is Ready to Pop
at The Street - Tue May 06, 1:07PM CDT
InterMune is telling a fundamentally and technically bullish story.

Use Options For A Chance To Buy ITMN At A 33% Discount
at The Street - Tue May 06, 10:49AM CDT
Looking back to 54 days ago, InterMune Inc. priced a 7,500,000 share secondary stock offering at $32.75 per share.

Why King Digital Entertainment, Intermune, and Pharmacyclics Jumped Today
Dan Caplinger, The Motley Fool - Motley Fool - Mon May 05, 7:05PM CDT
This morning, it looked as though Monday would be a horrible day for the stock market, as worries about the health of China's economic growth and ongoing turmoil in Ukraine combined to send stocks falling at the open. Slowly but surely, though,...

After Yesterday's Rally of 7.07% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon May 05, 5:00PM CDT
InterMune (NASDAQ:ITMN) traded in a range yesterday that spanned from a low of $32.29 to a high of $35.51. Yesterday, the shares gained 7.1%, which took the trading range above the 3-day high of $33.88 on volume of 3.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Why Intermune (ITMN) Stock Is Up Today
at The Street - Mon May 05, 12:38PM CDT
Intermune (ITMN) continues the momentum it gained from the release of its first quarter earnings results late last week as the biotech's stock is up 5.9% in trading today.

InterMune Up on Narrower-than-Expected Q1 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 05, 10:00AM CDT
InterMune's (ITMN) first-quarter 2014 adjusted loss per share of 60 cents was narrower than the Zacks Consensus Estimate of a loss of 62 cents.

Despite Esbriet Sales Nearly Tripling, InterMune's Loss Widens by 7%
Sean Williams, The Motley Fool - Motley Fool - Thu May 01, 6:49PM CDT
Momentum is building for biopharmaceutical mid-cap InterMune , which reported strong year-over-year sales gains in the first quarter for lead drug Esbriet, a treatment for idiopathic pulmonary fibrosis. For the quarter, InterMune reported a...

InterMune Reports First Quarter 2014 Financial Results, Clinical Development and Business Highlights
PR Newswire - Thu May 01, 3:01PM CDT
InterMune, Inc. (NASDAQ: ITMN) today announced results from operations for the first quarter ended March 31, 2014. The company also highlighted recent clinical development and business highlights, and raised its forward-looking revenue guidance for 2014.

Today's Biotech Stocks to Watch: BioMarin Pharmaceutical Inc, InterMune, Inc. and Seattle Genetics I
George Budwell, The Motley Fool - Motley Fool - Thu May 01, 8:30AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for BioMarin , InterMune , and Seattle Genetics .   BioMarin will hold an earnings call after the bell today Orphan drug specialist BioMarin will report...

Watch for InterMune to Potentially Pullback After Gaining 3.17% Yesterday
Comtex SmarTrend(R) - Tue Apr 29, 5:48PM CDT
InterMune (NASDAQ:ITMN) traded in a range yesterday that spanned from a low of $30.20 to a high of $32.07. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high of $30.73 on volume of 3.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

InterMune To Release First Quarter Financial Results On May 1
PR Newswire - Wed Apr 23, 7:00AM CDT
InterMune, Inc. (NASDAQ: ITMN) today announced that it will release its first quarter 2014 financial results at the close of the U.S. markets on Thursday, May 1, 2014. A live conference call and webcast will be hosted by InterMune at 4:30 p.m. Eastern time that same day.

After Yesterday's Decline of 1.55%, InterMune Offers Investors Better Value
Comtex SmarTrend(R) - Tue Apr 15, 5:23PM CDT
InterMune (NASDAQ:ITMN) traded in a range yesterday that spanned from a low of $24.27 to a high of $28.18. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $26.26 on volume of 4.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Shares of ITMN Up 98.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 15, 9:07AM CDT
SmarTrend identified an Uptrend for InterMune (NASDAQ:ITMN) on February 12th, 2014 at $13.97. In approximately 2 months, InterMune has returned 98.78% as of today's recent price of $27.77.

Biotech Tweet of the Week: Love Being Private
Brian Orelli, The Motley Fool - Motley Fool - Mon Apr 14, 4:57PM CDT
This week's tweet of the week comes from Luke Timmerman, with a quote from Moderna Therapeutics' President and CEO Stephane Bancel, who says he loves being a private company because he has more control over what information gets released. Public...

Insider Trading Alert - ITMN, DXCM And MU Traded By Insiders
at The Street - Fri Apr 04, 10:30AM CDT
Stocks with insider trader activity include ITMN, DXCM and MU

Tradable Biotech Stocks Events For the Second Quarter
at The Street - Thu Apr 03, 8:00AM CDT
The biotech sector's March "fluctuation" might be a temporary speed bump or the beginning of a longer downturn. Either way, investors can still count on the biotech catalyst trade for chills and thrills.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

SiteOne Joins S&P SmallCap 600 Amid KKR's Integer Buyout

Updated Category News Views 25

Changes on the SmallCap Horizon Starting off, SiteOne Landscape Supply (NYSE: SITE) is hopping onto the S&P SmallCap 600 bandwagon. This shift activates just as the market revs up on November 19, 2026. SiteOne is stepping in as Integer Holdings Corp. (NYSE: ITGR) makes its grand exit, a move prompted by a significant acquisition by KKR & Co. Inc. (NYSE: KKR). KKR’s...

Continue Reading
Lecanemab Shines in 5-Year Alzheimer's Study at CTAD

Updated Category News Views 19

Latest Lecanemab Results Turn Heads at CTAD 2026 The whispers buzzing out of the CTAD 2026 conference are about something promising for those in the trenches of Alzheimer's research: lecanemab. Yep, it's a name that's been bandied about before, and this time it's the long-term data doing the talking. The five-year results from Eisai and Biogen's lecanemab study are...

Continue Reading
Crocs to Present at Key Industry Conferences

Updated Category News Views 19

Crocs Set to Step into the Spotlight Alright, if there's one thing about Crocs, Inc. (NASDAQ: CROX) that never fails to surprise, it's how they constantly keep everyone on their toes. The iconic casual footwear brand with its whimsical, love-it-or-hate-it reputation is strapping in for not one but two hefty conferences. They've circled November 19 and December 1, 2026, on...

Continue Reading
Ainstein Expands Kansas Operations Amid Sensor Demand Surge

Updated Category News Views 16

Ainstein's Expansion Conquers New Heights in Radar Tech Ainstein just cranked open a whole new chapter right in the heart of Kansas. And believe me, it's not your average ribbon-cutting story. This shiny new facility in Lenexa is locked and loaded to roll out 44,000 radar sensors a year. It's part of a no-nonsense plan to keep up with soaring demand for their tech across...

Continue Reading
191 Schools Honored for Academic Growth Success

Updated Category News Views 80

Celebrating Educational Progress Nationwide In a world where numbers fly off the stock tickers and translate into dollar signs in some corner office, it's refreshingly humbling to find real gains being celebrated in the educational sector. Curriculum Associates has tipped their hat to 191 schools that have done something remarkable: they've pushed students to stretch...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 88

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 30

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading
Arbor Realty Trust Faces Securities Fraud Allegations

Updated Category News Views 5

Securities Lawsuit Against Arbor Realty Trust Looms Well, here we go again. Another day, another securities lawsuit hitting the headlines. This time it's Arbor Realty Trust (NYSE: ABR) getting caught in the crossfire, accused of pulling the wool over investors' eyes. Seems like 'truth in advertising' is just part of the PR playbook for some big shots. Understanding the...

Continue Reading
SwitchBot's Hub 4: A Step Toward a Connected Future

Updated Category News Views 37

Turning a House Into a Smart Home Haven Out of Tokyo and onto the world stage, SwitchBot's got something new cooking that might just shake up the smart home scene. They've launched the Hub 4, a gadget that's like the Swiss Army knife of home control. For those who like things simple, this is a one-hub-to-rule-them-all kind of deal. 101,000 Reasons to Notice Now, they...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 41

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading

Top 5 Most Recently Viewed Articles

Homrich Berg Welcomes Tim Tallach as New Tax Director

Updated Category News Views 319

Homrich Berg Welcomes Tim Tallach as Director Atlanta-based Homrich Berg, a prominent fee-only wealth advisor recognized for its comprehensive services, proudly announces the addition of Tim Tallach, J.D., CPA, as its new Director of Advanced Tax Planning and Family Office Services. This important addition to the team aims to fortify the firm's capabilities in serving...

Continue Reading
G-III Apparel Group Schedules First Quarter Earnings Call

Updated Category News Views 168

G-III Apparel Group Prepares for Earnings Announcement G-III Apparel Group, Ltd. (NASDAQ: GIII) is a prominent entity in the global fashion industry, recognized for its innovative design, sourcing, and marketing capabilities. The company has recently made an announcement regarding its first quarter fiscal 2026 earnings. This significant event is scheduled to take place...

Continue Reading
Mediaplanet's Initiative to Empower Small Businesses Nationwide

Updated Category News Views 117

Mediaplanet's Campaign for Small Business Success Small businesses play a pivotal role in stimulating the economy by fostering innovation, generating employment, and enhancing community engagement. However, in the face of today's complex business challenges, many entrepreneurs require support to navigate these waters successfully. To address this need, Mediaplanet has...

Continue Reading
New Barclays Report Highlights AI's Impact on Data Centre Demand

Updated Category News Views 529

Revolutionizing Data Centres: Insights from Barclays Research In a groundbreaking report, Barclays Research reveals that the rising influence of artificial intelligence (AI) could propel data centre usage in the US to triple by 2030. This report, titled “AI revolution: Meeting massive AI infrastructure demands,” presents a comprehensive analysis of how AI's growth...

Continue Reading
Major Renovation Completed at Aloft Phoenix-Airport Hotel

Updated Category News Views 274

Aloft Phoenix-Airport Unveils Major Renovation In an exciting development for travelers, the Aloft Phoenix-Airport has completed a comprehensive renovation that significantly upgrades its facilities. This 143-room hotel, managed by HEI Hotels & Resorts and owned by The RADCO Companies, has refreshed everything from guest rooms to public spaces, ensuring a modern and...

Continue Reading